OptiBiotix Health Plc announced that it intends to appoint Christopher Brinsmead CBE as a Director of the Company, subject to the completion of regulatory due diligence being carried out by the Company's Nomad. Chris will replace Peter Wennstrom as a director of the Company on confirmation of his appointment. Peter will continue in an advisory capacity for the Company following his resignation from the Board.